drugset / Trial / NCT03140956
Pharmacokinetic of Levodopa Study in Healthy Males
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of the study is to investigate PK of levodopa in plasma after repeated doses of 3 levodopa formulations given in combination with carbidopa and ODM-104 and compared to the PK of standard IR and CR levodopa formulations in the same combination.
Timeline
- Start
- 2017-04-19
- Primary completion
- 2017-07-03
- Completion
- 2017-08-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carbidopa | Unknown | 20 mg | — |
| Subject | Carbidopa | Unknown | 25 mg | — |
| Subject | Carbidopa | Unknown | 65 mg | — |
| Subject | Levodopa | Small molecule | 100 mg | — |
| Subject | ODM-104 | Unknown | 100 mg | — |